News

May 2014   We report on a pioneer program in México City designed to educate expectant mothers about both cord blood donation and private storage, made possible by the cooperation, to mutual benefit, of public and private institutions. Cordón Vital, a private (family) cord blood bank active in México City since 2001, together with Médica Sur Lomas Woman's Hospital, a private obstetric hospital (formerly Hospital Santa Teresa), formed an alliance in April 2007 with the public cord blood bank of the México Social Security Institute (IMSS) that was founded in 2005.

May 2014   Mesenchymal stem/stromal cells (MSC) are being widely studied in research and in clinical trials. Their useful properties include the ability to modulate the patient's immune system, promote cell growth, and to differentiate into more specialized cell types. This amazing potential has been explored in a large scope of diagnoses such as graft versus host disease (GvHD), rheumatoid arthritis, cardiomyopathy, liver cirrhosis, Alzheimer's, spinal cord injury, chronic wounds, and diabetes among many others [1,2].

Apr 2014   During the last 25 years, stem cells derived from umbilical cord blood have been used in more than 30,000 transplants performed worldwide for the treatment of over 80 diseases and disorders in both adults and children. The evolution of stem cell therapies has paved the way for further research being conducted through FDA-regulated clinical trials to uncover their potential in regenerative medicine applications.

Apr 2014   The Hearing Loss Association of America® (HLAA) is the nation's foremost membership and advocacy organization for people with hearing loss.

Apr 2014   This simple question has been lingering unanswered over private cord blood banks around the world for years. Despite compelling data on the growing therapeutic use of cord blood, both in terms of treatable diseases and numbers of therapies, often medical doctors are still reluctant to embrace the value of family cord blood banking. In many countries, such as Brazil, this sector is still plagued with mostly unfounded controversy, such as the "public versus private" banking debate.

Mar 2014   Borne's goal is to make childbirth safer and promote lifelong health for mothers and babies. In the UK, more than 1 in 10 babies are born too soon.

Mar 2014   Babies born prematurely often have serious medical complications that impact their lungs, brain, kidneys and intestinal systems. Stem cells in the umbilical cord blood and tissue, collected after the baby is born, may offer new treatment options for these premature babies. In an effort to understand the potential for the babies' newborn stem cells to be used in such treatments, ViaCord established a pilot program in partnership with Miracle Babies charity and Sharp Mary Birch Hospital in San Diego.

Mar 2014   Each year in the US, nearly 500,000 babies are born premature. That's 1 of every 8 infants born in the United States. A premature birth is when a baby is born before 37 completed weeks of pregnancy. A full-term pregnancy is 40 weeks. In almost all countries with reliable data, preterm birth rates are increasing.

Feb 2014   There is growing acceptance in the medical community that stem cells derived from cord blood have value as a therapy for pediatric neurologic injury. But what financial hurdles do parents face when they attempt to access that value for their children? In this article we present case studies of the out-of-pocket costs that parents face when they use their child's own (autologous) cord blood as therapy for cerebral palsy at Duke University Medical Center.

Feb 2014   There should be thousands of children worldwide who already have a cerebral palsy diagnosis and have their own cord blood in storage, based on the epidemiology of the disorder and the inventory of cord blood in family banks. If autologous cord blood therapy for cerebral palsy is accepted as a standard of care, those children are the immediate potential market for therapy. If therapy with matched cord blood donations is also accepted, even more children will potentially have access, but the cost of therapy will go up dramatically, and the search for a matching cord blood unit will complicate their ability to access this therapy.